CNTX Context Therapeutics Inc.
$0.35▼ -4.37%
Healthcare
Other
After hours
$0.36▲ +2.63%
Sep 11, 7:01 PM ET
Volume 816.2K
Avg Volume (10D) 1.35M
Key Metrics & Fundamentals
Market Cap
$32.19M
P/E Ratio
–
Div Yield
–%
52W Range
0.34 - 3.62
% vs 50 MA
-33.50%
% vs 200 MA
-78.43%
RSI-14
28.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.21
Free Cash Flow
-$11.54M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$14.96M
COGS
–
Operating Exp
$14.97M
Operating Income
-$14.97M
EBIT
-$14.97M
Pretax Income
-$14.56M
Net Income
-$14.56M
EPS (Diluted)
-0.15
Price & Volume History
Loading chart…
Recent News
Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
GlobeNewswire · Sep 9, 2026 11:30 AM
Context drops bispecific T-cell engager on cost-cutting initiative
Pharmaceutical Technology · Aug 7, 2026 11:05 AM
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
GlobeNewswire · Aug 7, 2026 9:37 AM
Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
GlobeNewswire · Aug 5, 2026 8:14 PM
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Jul 10, 2026 8:05 PM
Context Therapeutics Joins Russell 2000, Russell 3000 Indexes
MT Newswires · Jul 6, 2026 8:17 PM
Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes
GlobeNewswire · Jul 6, 2026 8:07 PM
Maxim Says Context Therapeutics (CNTX)’s Share Pullback Is an Overreaction; Remains Bullish
Insider Monkey · Jul 5, 2026 10:08 PM
CNTX Hits Worst Day In History After Ovarian Cancer Trial Data — But Analysts See Buying Opportunity In Dip
Stocktwits · Jun 15, 2026 9:20 PM
Small Biotech Context Therapeutics Reports 29% Response Rate In Ovarian Cancer Study
Benzinga · Jun 15, 2026 3:10 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CNTX's money flow as a full page
Social Sentiment
Avg +0.73 · 3 posts
TradeNewsTrading is getting me used to do my daily wage with single trades
r/options · Oct 22, 2024
The author details a positive trading experience with CNTX.
positive
+0.60
TradeDiscussionThis even feels illegal - doing +100% profit on multiple trades a week
r/options · Oct 21, 2024
The author scored a 50% profit on CNTX, indicating a positive sentiment.
positive
+0.80
TradeDiscussionThis even feels like cheating - 2 days in a row hitting way over 100% wins
r/options · Oct 17, 2024
The author details a 50% gain on CNTX, indicating a favorable experience.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.